Drug shortages remain low in 2021 as FDA's prevention efforts grow, report to Congress says

Supply chain snafus and high-profile drug and vaccine shortages and quality issues (e.g. Emergent’s Baltimore site) have played a major role during the pandemic so far. But in a new report to Congress, the FDA said that it’s continuing to see drug shortages decline ⁠— from a high of 250 drug shortages in 2011 to just 41 in 2021.